For the study, researchers examined CMS data on opioid prescriptions compiled from 2010-15. Analysis revealed individual states dispensed an average of 23.1 million daily doses of opioids each year to Part D patients.
Medical marijuana laws were associated with a 2.1 million reduction in opioid daily doses for states. Specifically, researchers found states with active legalized marijuana dispensaries experienced a 14.4 percent reduction in the use of prescription opioids from 2010-15.
“Combined with previously published studies suggesting cannabis laws are associated with lower opioid mortality, these findings further strengthen arguments in favor of considering medical applications of cannabis as one tool in the policy arsenal that can be used to diminish the harm of prescription opioids,” concluded the study’s authors.
To read the full study, click here.
More articles on opioids:
Overdose deaths surged since 2010, despite prescription opioid decline: 3 findings
Facebook cracks down on opioid-based hashtags on Instagram: 5 things to know
Florida AG says state will file opioid lawsuit against drug companies
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
